BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28947129)

  • 1. The highly anxious individual presenting for Huntington disease-predictive genetic testing: the psychiatrist's role in assessment and counseling.
    Groves M
    Handb Clin Neurol; 2017; 144():99-105. PubMed ID: 28947129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Confluence of Psychiatric Symptoms and Neurodegenerative Disease: Impact on Genetic Counseling.
    Goldman JS; Huey ED; Thorne DZ
    J Genet Couns; 2017 Jun; 26(3):435-441. PubMed ID: 28013481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic testing for Huntington disease.
    Quaid KA
    Handb Clin Neurol; 2017; 144():113-126. PubMed ID: 28947110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive genetic tests in neurodegenerative disorders: a methodological approach integrating psychological counseling for at-risk individuals and referring clinicians.
    Mariotti C; Ferruta A; Gellera C; Nespolo C; Fancellu R; Genitrini S; Di Bella D; Panzeri M; Nanetti L; Tomasello C; Taroni F; Foresti G; Astori S
    Eur Neurol; 2010; 64(1):33-41. PubMed ID: 20588047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Psychosocial aspects in presymptomatic testing for genetic diseases. Experiences after 2 years of counseling in Huntington disease].
    Blomhoff S; Malt U; Weisaeth L
    Tidsskr Nor Laegeforen; 1995 Jan; 115(1):27-9. PubMed ID: 7846655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early testing for Huntington disease in children: pros and cons.
    Toufexis M; Gieron-Korthals M
    J Child Neurol; 2010 Apr; 25(4):482-4. PubMed ID: 19808987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pitfalls in counseling for predictive testing in Huntington disease.
    Demyttenaere K; Evers-Kiebooms G; Decruyenaere M
    Birth Defects Orig Artic Ser; 1992; 28(1):105-11. PubMed ID: 1340218
    [No Abstract]   [Full Text] [Related]  

  • 8. [Psychological aspects of presymptomatic diagnosis in Huntington disease].
    Bondor B; Kárteszi J; Hadzsiev K; Kellermayer R; Melegh B; Kosztolányi G
    Orv Hetil; 2008 Mar; 149(13):609-12. PubMed ID: 18353742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Changing Age of Individuals Seeking Presymptomatic Genetic Testing for Huntington Disease.
    Holman MA; Quillin J; York TP; Testa CM; Rosen AR; Norris VW
    J Genet Couns; 2018 Sep; 27(5):1157-1166. PubMed ID: 29460111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canadian experience with predictive testing for Huntington disease: lessons for genetic testing centers and policy makers.
    Chapman MA
    Am J Med Genet; 1992 Feb; 42(4):491-8. PubMed ID: 1535176
    [No Abstract]   [Full Text] [Related]  

  • 11. Genetic counseling and testing for Huntington's disease: A historical review.
    Nance MA
    Am J Med Genet B Neuropsychiatr Genet; 2017 Jan; 174(1):75-92. PubMed ID: 27174011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. General practitioners and predictive genetic testing for late-onset diseases in Flanders: what are their opinions and do they want to be involved?
    Welkenhuysen M; Evers-Kiebooms G
    Community Genet; 2002; 5(2):128-37. PubMed ID: 12739519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive testing for Huntington disease in Canada: the experience of those receiving an increased risk.
    Bloch M; Adam S; Wiggins S; Huggins M; Hayden MR
    Am J Med Genet; 1992 Feb; 42(4):499-507. PubMed ID: 1535177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience over fifteen years with a protocol for predictive testing for Huntington disease.
    Dufrasne S; Roy M; Galvez M; Rosenblatt DS
    Mol Genet Metab; 2011 Apr; 102(4):494-504. PubMed ID: 21220204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ethical justification for minimal paternalism in the use of the predictive test for Huntington's disease.
    DeGrazia D
    J Clin Ethics; 1991; 2(4):219-28; discussion 228-40. PubMed ID: 1839509
    [No Abstract]   [Full Text] [Related]  

  • 16. Genetic testing and mental health: the model of Huntington disease.
    Williams JK; Schutte DL
    Online J Issues Nurs; 2000; 5(3):3. PubMed ID: 11380269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive testing of 25 percent at-risk individuals for Huntington disease (1987-1997).
    Maat-Kievit A; Vegter-Van Der Vlis M; Zoeteweij M; Losekoot M; van Haeringen A; Roos RA
    Am J Med Genet; 1999 Dec; 88(6):662-8. PubMed ID: 10581487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reverse pre-symptomatic testing for Huntington disease: double disclosure when 25% at-risk children reveal the genetic status to their parent.
    Bonnard A; Herson A; Gargiulo M; Durr A
    Eur J Hum Genet; 2019 Jan; 27(1):22-27. PubMed ID: 30206353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Predictive diagnostics in chorea huntington: psychotherapeutic implications for counselling].
    Richartz-Salzburger E; Mau-Holzmann U; Schott KJ; Buchkremer G
    Psychiatr Prax; 2006 Jul; 33(5):211-7. PubMed ID: 16802259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attitudes toward direct predictive testing for the Huntington disease gene. Relevance for other adult-onset disorders. The Canadian Collaborative Group on Predictive Testing for Huntington Disease.
    Babul R; Adam S; Kremer B; Dufrasne S; Wiggins S; Huggins M; Theilmann J; Bloch M; Hayden MR
    JAMA; 1993 Nov; 270(19):2321-5. PubMed ID: 8230594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.